Dr. Sean Sullivan is a Program Officer for the Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Program. In this role, he oversees the glucose control grants portfolio, identifying and evaluating new devices and technologies with the goal of reducing the burden for people living with T1D.

Previously, Sean was a staff engineer in diabetes care research and development at Becton Dickinson. There, his focus was on new product development, where he led and was part of a number of cross-functional teams to bring new diabetes injection devices to market. With considerable expertise in technology assessment, market research, and intellectual property, Sean is the author of a number of peer-reviewed publications and two U.S. and world patents.

Sean earned a joint Ph.D. in biomedical engineering from Georgia Institute of Technology and Emory University and a Bachelor of Science degree in chemical engineering from the University of Notre Dame.